As of Oct 20
| -0.01 / -0.35%|
The 6 analysts offering 12-month price forecasts for Synergy Pharmaceuticals Inc have a median target of 9.50, with a high estimate of 13.00 and a low estimate of 2.50. The median estimate represents a +238.08% increase from the last price of 2.81.
The current consensus among 6 polled investment analysts is to Buy stock in Synergy Pharmaceuticals Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.